We in India greatly value the role we are able to play in the fight against leprosy. India has around 70% of the world’s leprosy cases and we look forward to the day when leprosy is eliminated and patients suffering from leprosy are integrated into mainstream society,” said Ranjit Shahani, Vice Chairman & Managing Director, Novartis India Limited.